Health Care
California
Coronavirus Shows State Push for Public Transit is Hazardous to our Health
On March 11, 2020, the Legislative Analyst’s Office published a handout, which included a passage on the climate benefits of mass transit over private vehicles. Within days, a spreading virus made the case that our cars are a more hygienic means of travel than public transportation, where humanity is crammed ...
Coronavirus
Dr. Henry Miller Weighs in on the Latest Coronavirus Updates with Lars Larson
Lars Larson and PRI’s Dr. Henry Miller discuss the decision by several state politicians to limit the type of medication available to doctors due to the coronavirus epidemic. Dr. Miller explains that the COVID-19 outbreak has led to a bending of regulatory guidelines, usually for the better.
Coronavirus
Dr. Henry Miller and John Batchelor Explain Coronavirus Antibody Testing
Dr. Henry Miller joins the John Batchelor Show for his weekly discussion on the coronavirus pandemic and the latest developments about COVID-19. Dr. Miller and John Batchelor debate the benefits of serology, or antibody testing, from patients with diagnosed or suspected of having the novel coronavirus and the different rates ...
Commentary
Dr. Henry Miller Discusses Coronavirus Delaying Cancer Patient Treatments
Title: COVID-19 Pandemic Delaying Treatments of Hematologic Cancers By: John Schieszer Institutional restrictions due to the coronavirus disease 2019 (COVID-19) pandemic are taking a large toll on patients with hematologic cancers. Some medical centers have canceled treatments and all centers have altered their policies and procedures. Starting in March, elective ...
Blog
Not Even The Threat Of Spreading COVID-19 Can Change California’s Plastic Bag Ban
While several states are rethinking their single-use plastic bag bans for health reasons during the COVID-19 pandemic, California, which led the nation down the misguided path to prohibition, has yet to act. It should have been the first to suspend its ban. But here we wait while other states are ...
Commentary
Dr. Henry Miller Answers Viewer Questions as Featured Expert on Fox News Live Blog
Read answers from PRI Senior Fellow Dr. Henry Miller on Foxnews.com’s “Coronavirus Live Blog.” Dr. Miller answered written questions on Wednesday, April 1 about the coronavirus, next steps, and more. Read Dr. Miller’s responses here: https://www.foxnews.com/health/coronavirus-live-blog-former-fda-official-dr-henry-miller.
Charter Schools
Coronavirus school shutdowns foster online learning alternatives
Along with other sectors of society, education has been greatly affected by the coronavirus, with schools closed across America. Yet, as in other fields, innovators in education have responded with learning mechanisms and models that allow students to continue to learn while the country shuts down brick-and-mortar institutions. As it ...
Blog
Amidst Coronavirus-Fueled Economic Downturn, State Leaders Must Suspend Government Barriers to Opportunity
In his “Breaking Down Barriers to Opportunity” series, PRI’s Dr. Wayne Winegarden has argued that one of the most important ways that elected officials can help to lift people up the economy ladder is by embracing policies that encourage entrepreneurship. As many Californians struggle to stay afloat financially during the ...
Drug Pricing
Sally C. Pipes Explains the Danger of Drug Price Controls with Coronavirus
PRI’s Sally C. Pipes, President, CEO, and Thomas W. Smith Fellow in Health Care Policy, joined the Kirby Nation to discuss the danger of drug price controls and American medical innovation. Pipes explains that roughly 4,500 new drugs are in various stage of development, with an estimated three-quarters of those ...
Commentary
Expand Pharmacists’ Authority To Promote Access To Forthcoming COVID-19 Vaccine
Private pharmaceutical companies and the National Institutes of Health have outdone themselves. Thanks to the funding provided by the NIH, a Phase 1 clinical trial for a COVID-19 vaccine is underway. In separate efforts, Inovio, Sanofi, Vaxart, GlaxoSmithKline, and Johnson & Johnson are all developing potential vaccines. In total, “about 35 companies ...
Coronavirus Shows State Push for Public Transit is Hazardous to our Health
On March 11, 2020, the Legislative Analyst’s Office published a handout, which included a passage on the climate benefits of mass transit over private vehicles. Within days, a spreading virus made the case that our cars are a more hygienic means of travel than public transportation, where humanity is crammed ...
Dr. Henry Miller Weighs in on the Latest Coronavirus Updates with Lars Larson
Lars Larson and PRI’s Dr. Henry Miller discuss the decision by several state politicians to limit the type of medication available to doctors due to the coronavirus epidemic. Dr. Miller explains that the COVID-19 outbreak has led to a bending of regulatory guidelines, usually for the better.
Dr. Henry Miller and John Batchelor Explain Coronavirus Antibody Testing
Dr. Henry Miller joins the John Batchelor Show for his weekly discussion on the coronavirus pandemic and the latest developments about COVID-19. Dr. Miller and John Batchelor debate the benefits of serology, or antibody testing, from patients with diagnosed or suspected of having the novel coronavirus and the different rates ...
Dr. Henry Miller Discusses Coronavirus Delaying Cancer Patient Treatments
Title: COVID-19 Pandemic Delaying Treatments of Hematologic Cancers By: John Schieszer Institutional restrictions due to the coronavirus disease 2019 (COVID-19) pandemic are taking a large toll on patients with hematologic cancers. Some medical centers have canceled treatments and all centers have altered their policies and procedures. Starting in March, elective ...
Not Even The Threat Of Spreading COVID-19 Can Change California’s Plastic Bag Ban
While several states are rethinking their single-use plastic bag bans for health reasons during the COVID-19 pandemic, California, which led the nation down the misguided path to prohibition, has yet to act. It should have been the first to suspend its ban. But here we wait while other states are ...
Dr. Henry Miller Answers Viewer Questions as Featured Expert on Fox News Live Blog
Read answers from PRI Senior Fellow Dr. Henry Miller on Foxnews.com’s “Coronavirus Live Blog.” Dr. Miller answered written questions on Wednesday, April 1 about the coronavirus, next steps, and more. Read Dr. Miller’s responses here: https://www.foxnews.com/health/coronavirus-live-blog-former-fda-official-dr-henry-miller.
Coronavirus school shutdowns foster online learning alternatives
Along with other sectors of society, education has been greatly affected by the coronavirus, with schools closed across America. Yet, as in other fields, innovators in education have responded with learning mechanisms and models that allow students to continue to learn while the country shuts down brick-and-mortar institutions. As it ...
Amidst Coronavirus-Fueled Economic Downturn, State Leaders Must Suspend Government Barriers to Opportunity
In his “Breaking Down Barriers to Opportunity” series, PRI’s Dr. Wayne Winegarden has argued that one of the most important ways that elected officials can help to lift people up the economy ladder is by embracing policies that encourage entrepreneurship. As many Californians struggle to stay afloat financially during the ...
Sally C. Pipes Explains the Danger of Drug Price Controls with Coronavirus
PRI’s Sally C. Pipes, President, CEO, and Thomas W. Smith Fellow in Health Care Policy, joined the Kirby Nation to discuss the danger of drug price controls and American medical innovation. Pipes explains that roughly 4,500 new drugs are in various stage of development, with an estimated three-quarters of those ...
Expand Pharmacists’ Authority To Promote Access To Forthcoming COVID-19 Vaccine
Private pharmaceutical companies and the National Institutes of Health have outdone themselves. Thanks to the funding provided by the NIH, a Phase 1 clinical trial for a COVID-19 vaccine is underway. In separate efforts, Inovio, Sanofi, Vaxart, GlaxoSmithKline, and Johnson & Johnson are all developing potential vaccines. In total, “about 35 companies ...
